| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24c39e4dc286833abc38483ab3822aee |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-4483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-1451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29D11-00826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-5223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-1241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-027 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-13 |
| filingDate |
2014-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d61689c5f96a12eb9e94a74741a8d05 |
| publicationDate |
2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2015107323-A |
| titleOfInvention |
Ophthalmic lens with retinal neovascularization monitoring system |
| abstract |
PROBLEM TO BE SOLVED: To provide an ophthalmic device having a retinal neovascularization monitoring system and an associated method. In some embodiments, an ophthalmic device is a contact lens having a retinal neovascularization monitoring system that can be used to monitor temporal changes in pulsating blood vessels that form part of retinal neovascularization. it can. In addition, the retinal neovascularization monitoring system may include elements for delivering signals including audible and / or visual messages to the user that may be useful for confirming abnormal conditions such as heart failure without delay. The audible and / or visual message may be a signal that informs the user using one or both of the ophthalmic device and the wireless device in communication with the ophthalmic device. [Selection] Figure 1A |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2019073676-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019073676-A1 |
| priorityDate |
2013-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |